Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALV-100 for Maintenance of Weight Loss in Overweight or Obese Patients
NCT07837973Phase 2Recruiting
- Start
- Aug 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of ALV-100 in obesity. Started Aug 2026; status: recruiting.
02
Drugs
ALV-100
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07837973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837973.